Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Soleil Boughton sold 2,503 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $12.56, for a total transaction of $31,437.68. Following the sale, the insider now directly owns 161,860 shares of the company’s stock, valued at approximately $2,032,961.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Soleil Boughton also recently made the following trade(s):
- On Monday, April 15th, Soleil Boughton sold 2,503 shares of Hims & Hers Health stock. The shares were sold at an average price of $13.95, for a total value of $34,916.85.
- On Monday, April 1st, Soleil Boughton sold 2,503 shares of Hims & Hers Health stock. The stock was sold at an average price of $15.65, for a total value of $39,171.95.
- On Wednesday, March 13th, Soleil Boughton sold 63,621 shares of Hims & Hers Health stock. The shares were sold at an average price of $15.17, for a total value of $965,130.57.
- On Friday, February 9th, Soleil Boughton sold 4,080 shares of Hims & Hers Health stock. The shares were sold at an average price of $10.03, for a total transaction of $40,922.40.
- On Monday, February 12th, Soleil Boughton sold 22,839 shares of Hims & Hers Health stock. The shares were sold at an average price of $10.03, for a total transaction of $229,075.17.
Hims & Hers Health Price Performance
Shares of NYSE:HIMS opened at $12.50 on Thursday. The firm has a 50 day moving average of $13.85 and a 200 day moving average of $10.19. Hims & Hers Health, Inc. has a 52 week low of $5.65 and a 52 week high of $17.16.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of HIMS. Oak Ridge Investments LLC purchased a new position in Hims & Hers Health during the first quarter worth approximately $2,066,000. Diversify Advisory Services LLC acquired a new stake in shares of Hims & Hers Health in the first quarter valued at about $701,000. Principal Financial Group Inc. raised its holdings in Hims & Hers Health by 17.9% in the 1st quarter. Principal Financial Group Inc. now owns 16,655 shares of the company’s stock valued at $258,000 after acquiring an additional 2,525 shares during the last quarter. Cornerstone Investment Partners LLC purchased a new position in Hims & Hers Health during the first quarter worth approximately $161,000. Finally, First National Trust Co acquired a new position in shares of Hims & Hers Health during the 1st quarter valued at about $232,000. 63.52% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have commented on HIMS. TheStreet raised shares of Hims & Hers Health from a “d” rating to a “c” rating in a research report on Monday, March 4th. Imperial Capital upgraded Hims & Hers Health from an “in-line” rating to an “outperform” rating and set a $16.00 price target on the stock in a research note on Wednesday, February 28th. Guggenheim upped their price objective on Hims & Hers Health from $15.00 to $17.00 and gave the company a “buy” rating in a research report on Tuesday, February 27th. Citigroup raised their target price on Hims & Hers Health from $12.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, February 27th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $15.00 price target (down previously from $17.00) on shares of Hims & Hers Health in a research report on Tuesday, April 16th. Five analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $14.85.
Check Out Our Latest Analysis on Hims & Hers Health
Hims & Hers Health Company Profile
Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Read More
- Five stocks we like better than Hims & Hers Health
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- AMD is Down 35%. Now is the Time to Buy the Dip
- 3 Fintech Stocks With Good 2021 Prospects
- Amazon Stands Tall: New Highs Are in Sight
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.